Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$18.33 - $27.25 $29,144 - $43,327
-1,590 Reduced 7.64%
19,217 $477,000
Q4 2024

Feb 14, 2025

SELL
$15.3 - $20.33 $15,881 - $21,102
-1,038 Reduced 4.75%
20,807 $392,000
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $557,047 - $688,335
21,845 New
21,845 $624,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.09B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.